Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Ken Griffin Takes 5% Stake In QLogic

We can compare QLogic to Emulex Corporation (NYSE:ELX), Cisco Systems, Inc. (NASDAQ:CSCO), Intel Corporation (NASDAQ:INTC), and Broadcom Corporation (NASDAQ:BRCM). Emulex, possibly the closest peer, has also been experiencing falling earnings and now has cash representing a large share of its valuation. In forward earnings and cash flow terms it is slightly cheaper than QLogic though the business is smaller and potentially a riskier investment. Intel and Cisco both trade at 10 times forward earnings estimates, and have market capitalizations of over $100 billion. Intel has been struggling, with a small decline in revenue in the fourth quarter of 2012 versus a year earlier causing a 27% drop in earnings, but that stock also pays a dividend yield above 4%. Cisco continues to report growth numbers and we think it’s worth considering as a value stock. Broadcom’s performance has not been particularly good recently, and as a result the trailing P/E is above 20; however, the sell-side expects the company to recover and return to a higher level of earnings.

It’s interesting to see Citadel getting involved with the company, but from our perspective QLogic’s financials don’t make it attractive enough to be worth buying. The substantial cash of course prevents it from being a short as well, but value investors might be better off considering Cisco or possibly Intel.

Disclosure: I own no shares of any stocks mentioned in this article.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!